$OPHT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IVERIC bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IVERIC bio, Inc.. Get notifications about new insider transactions in IVERIC bio, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 20 2021 | OPHT | IVERIC bio, Inc. | Blumenkranz Mark S. | Director | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
May 20 2021 | OPHT | IVERIC bio, Inc. | Blumenkranz Mark S. | Director | Option Exercise | A | 6.82 | 15,500 | 105,710 | 15,500 | |
May 04 2021 | OPHT | IVERIC bio, Inc. | Dugel Pravin | President | Option Exercise | A | 0.00 | 17,250 | 0 | 17,250 | |
May 04 2021 | OPHT | IVERIC bio, Inc. | Dugel Pravin | President | Option Exercise | A | 7.17 | 35,000 | 250,950 | 35,000 | |
Apr 05 2021 | OPHT | IVERIC bio, Inc. | Dugel Pravin | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
Apr 05 2021 | OPHT | IVERIC bio, Inc. | Dugel Pravin | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 50,000 | 0 | 150,000 | |
Apr 05 2021 | OPHT | IVERIC bio, Inc. | Dugel Pravin | EVP, Chief Strategy ... | Sell | S | 6.34 | 28,301 | 179,428 | 41,699 | 70 K to 41.7 K (-40.43 %) |
Apr 05 2021 | OPHT | IVERIC bio, Inc. | Dugel Pravin | EVP, Chief Strategy ... | Buy | M | 0.00 | 20,000 | 0 | 70,000 | 50 K to 70 K (+40.00 %) |
Apr 05 2021 | OPHT | IVERIC bio, Inc. | Dugel Pravin | EVP, Chief Strategy ... | Buy | M | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Jan 05 2021 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 32,500 | 0 | 32,500 | |
Jan 05 2021 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Sell | S | 6.85 | 11,875 | 81,344 | 80,165 | 92 K to 80.2 K (-12.90 %) |
Jan 05 2021 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Buy | M | 0.00 | 32,500 | 0 | 92,040 | 59.5 K to 92 K (+54.59 %) |
Dec 22 2020 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Option Exercise | A | 0.00 | 57,500 | 0 | 57,500 | |
Dec 22 2020 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Option Exercise | A | 7.50 | 115,000 | 862,500 | 115,000 | |
Dec 22 2020 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Dec 22 2020 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Option Exercise | A | 7.50 | 100,000 | 750,000 | 100,000 | |
Dec 22 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President & CEO | Option Exercise | A | 0.00 | 146,630 | 0 | 146,630 | |
Dec 22 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President & CEO | Option Exercise | A | 7.50 | 293,130 | 2,198,475 | 293,130 | |
Dec 22 2020 | OPHT | IVERIC bio, Inc. | Dugel Pravin | EVP, Chief Strategy ... | Option Exercise | A | 0.00 | 55,000 | 0 | 55,000 | |
Dec 22 2020 | OPHT | IVERIC bio, Inc. | Dugel Pravin | EVP, Chief Strategy ... | Option Exercise | A | 7.50 | 110,000 | 825,000 | 110,000 | |
Dec 22 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Option Exercise | A | 0.00 | 102,630 | 0 | 102,630 | |
Dec 22 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Option Exercise | A | 7.50 | 205,150 | 1,538,625 | 205,150 | |
Dec 15 2020 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Option Exercise | M | 0.00 | 12,500 | 0 | 25,000 | |
Dec 15 2020 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Sell | S | 7.16 | 4,527 | 32,413 | 65,841 | 70.4 K to 65.8 K (-6.43 %) |
Dec 15 2020 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Buy | M | 0.00 | 12,500 | 0 | 70,368 | 57.9 K to 70.4 K (+21.60 %) |
Dec 15 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Option Exercise | M | 0.00 | 17,200 | 0 | 34,400 | |
Dec 15 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Sell | S | 7.16 | 9,270 | 66,373 | 70,113 | 79.4 K to 70.1 K (-11.68 %) |
Dec 15 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Buy | M | 0.00 | 17,200 | 0 | 79,383 | 62.2 K to 79.4 K (+27.66 %) |
Dec 15 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Option Exercise | M | 0.00 | 22,950 | 0 | 45,900 | |
Dec 15 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Buy | M | 0.00 | 22,950 | 0 | 273,773 | 250.8 K to 273.8 K (+9.15 %) |
Dec 15 2020 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 12,500 | 0 | 25,000 | |
Dec 15 2020 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Buy | M | 0.00 | 12,500 | 0 | 59,540 | 47 K to 59.5 K (+26.57 %) |
Dec 11 2020 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Option Exercise | M | 0.00 | 10,000 | 0 | 30,000 | |
Dec 11 2020 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Sell | S | 6.96 | 3,676 | 25,585 | 57,868 | 61.5 K to 57.9 K (-5.97 %) |
Dec 11 2020 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Buy | M | 0.00 | 10,000 | 0 | 61,544 | 51.5 K to 61.5 K (+19.40 %) |
Dec 11 2020 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 10,000 | 0 | 30,000 | |
Dec 11 2020 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Buy | M | 0.00 | 10,000 | 0 | 47,040 | 37 K to 47 K (+27.00 %) |
Dec 11 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Option Exercise | M | 0.00 | 23,750 | 0 | 71,250 | |
Dec 11 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Buy | M | 0.00 | 23,750 | 0 | 250,823 | 227.1 K to 250.8 K (+10.46 %) |
Dec 11 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Option Exercise | A | 0.00 | 17,813 | 0 | 53,437 | |
Dec 11 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Sell | S | 6.96 | 9,602 | 66,830 | 62,183 | 71.8 K to 62.2 K (-13.38 %) |
Dec 11 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Buy | M | 0.00 | 17,813 | 0 | 71,785 | 54 K to 71.8 K (+33.00 %) |
Jul 17 2020 | OPHT | IVERIC bio, Inc. | Blumenkranz Mark S. | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Jul 17 2020 | OPHT | IVERIC bio, Inc. | Blumenkranz Mark S. | Director | Option Exercise | A | 4.48 | 31,000 | 138,880 | 31,000 | |
Jul 06 2020 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 7,500 | 0 | 0 | |
Jul 06 2020 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Buy | M | 0.00 | 7,500 | 0 | 33,707 | 26.2 K to 33.7 K (+28.62 %) |
Jun 23 2020 | OPHT | IVERIC bio, Inc. | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 34,282 | 0 | 0 | 34.3 K to 0 (-100.00 %) |
Jun 23 2020 | OPHT | IVERIC bio, Inc. | Versant Venture Capital IV, L. ... | 10% Owner | Buy | J | 0.00 | 34,282 | 0 | 34,282 | 0 to 34.3 K |
Jun 23 2020 | OPHT | IVERIC bio, Inc. | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 21,597 | 0 | 10,798 | 32.4 K to 10.8 K (-66.67 %) |
Jun 23 2020 | OPHT | IVERIC bio, Inc. | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 3,428,221 | 0 | 1,714,111 | 5.1 M to 1.7 M (-66.67 %) |
Jun 11 2020 | OPHT | IVERIC bio, Inc. | Bolte Axel | Director | Option Exercise | A | 4.14 | 16,000 | 66,240 | 16,000 | |
Jun 11 2020 | OPHT | IVERIC bio, Inc. | Roberts Calvin W. | Director | Option Exercise | A | 4.14 | 16,000 | 66,240 | 16,000 | |
Jun 11 2020 | OPHT | IVERIC bio, Inc. | Graves Adrienne L | Director | Option Exercise | A | 4.14 | 16,000 | 66,240 | 16,000 | |
Jun 11 2020 | OPHT | IVERIC bio, Inc. | Henderson Jane | Director | Option Exercise | A | 4.14 | 16,000 | 66,240 | 16,000 | |
Apr 03 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Option Exercise | M | 0.00 | 18,750 | 0 | 0 | |
Apr 03 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Buy | M | 0.00 | 18,750 | 0 | 225,061 | 206.3 K to 225.1 K (+9.09 %) |
Jan 07 2020 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Option Exercise | M | 0.00 | 700 | 0 | 0 | |
Jan 07 2020 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Sell | S | 8.07 | 293 | 2,365 | 40,983 | 41.3 K to 41 K (-0.71 %) |
Jan 07 2020 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Buy | M | 0.00 | 700 | 0 | 41,276 | 40.6 K to 41.3 K (+1.73 %) |
Jan 07 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Option Exercise | M | 0.00 | 6,250 | 0 | 0 | |
Jan 07 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Sell | S | 8.07 | 3,367 | 27,172 | 53,972 | 57.3 K to 54 K (-5.87 %) |
Jan 07 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Buy | M | 0.00 | 6,250 | 0 | 57,339 | 51.1 K to 57.3 K (+12.23 %) |
Dec 16 2019 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 12,500 | 0 | 37,500 | |
Dec 16 2019 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Buy | M | 0.00 | 12,500 | 0 | 26,207 | 13.7 K to 26.2 K (+91.19 %) |
Dec 16 2019 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Option Exercise | M | 0.00 | 22,950 | 0 | 68,850 | |
Dec 16 2019 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Buy | M | 0.00 | 22,950 | 0 | 199,804 | 176.9 K to 199.8 K (+12.98 %) |
Dec 16 2019 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Option Exercise | M | 0.00 | 17,200 | 0 | 51,600 | |
Dec 16 2019 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Sell | S | 6.60 | 9,275 | 61,215 | 51,089 | 60.4 K to 51.1 K (-15.37 %) |
Dec 16 2019 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Buy | M | 0.00 | 17,200 | 0 | 60,364 | 43.2 K to 60.4 K (+39.85 %) |
Dec 16 2019 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Option Exercise | M | 0.00 | 12,500 | 0 | 37,500 | |
Dec 16 2019 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Sell | S | 6.60 | 4,530 | 29,898 | 40,576 | 45.1 K to 40.6 K (-10.04 %) |
Dec 16 2019 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Buy | M | 0.00 | 12,500 | 0 | 45,106 | 32.6 K to 45.1 K (+38.34 %) |
Dec 11 2019 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Option Exercise | A | 0.00 | 65,000 | 0 | 65,000 | |
Dec 11 2019 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Dec 11 2019 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Option Exercise | A | 5.22 | 75,000 | 391,500 | 75,000 | |
Dec 11 2019 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Option Exercise | A | 0.00 | 65,000 | 0 | 65,000 | |
Dec 11 2019 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Dec 11 2019 | OPHT | IVERIC bio, Inc. | Westby Keith | SVP & COO | Option Exercise | A | 5.22 | 75,000 | 391,500 | 75,000 | |
Dec 11 2019 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Option Exercise | A | 0.00 | 95,000 | 0 | 95,000 | |
Dec 11 2019 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Option Exercise | A | 5.22 | 190,000 | 991,800 | 190,000 | |
Dec 11 2019 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Buy | P | 4.00 | 62,500 | 250,000 | 176,854 | 114.4 K to 176.9 K (+54.65 %) |
Dec 11 2019 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Option Exercise | A | 0.00 | 71,250 | 0 | 71,250 | |
Dec 11 2019 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Option Exercise | A | 5.22 | 142,500 | 743,850 | 142,500 | |
Nov 18 2019 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Buy | P | 3.12 | 15,000 | 46,851 | 114,354 | 99.4 K to 114.4 K (+15.10 %) |
Jul 03 2019 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 7,500 | 0 | 7,500 | |
Jul 03 2019 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Sell | S | 1.25 | 2,773 | 3,466 | 13,707 | 16.5 K to 13.7 K (-16.83 %) |
Jul 03 2019 | OPHT | IVERIC bio, Inc. | Carroll David Francis | SVP, CFO and Treasu ... | Buy | M | 0.00 | 7,500 | 0 | 16,480 | 9 K to 16.5 K (+83.52 %) |
May 16 2019 | OPHT | IVERIC bio, Inc. | Henderson Jane | Director | Option Exercise | A | 1.39 | 16,000 | 22,240 | 16,000 | |
May 16 2019 | OPHT | IVERIC bio, Inc. | Graves Adrienne L | Director | Option Exercise | A | 1.39 | 16,000 | 22,240 | 16,000 | |
May 16 2019 | OPHT | IVERIC bio, Inc. | Redlick David E | Director | Option Exercise | A | 1.39 | 16,000 | 22,240 | 16,000 | |
May 16 2019 | OPHT | IVERIC bio, Inc. | Bolte Axel | Director | Option Exercise | A | 1.39 | 16,000 | 22,240 | 16,000 | |
May 13 2019 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Buy | P | 1.48 | 25,000 | 37,000 | 93,105 | 68.1 K to 93.1 K (+36.71 %) |
Jan 16 2019 | OPHT | Ophthotech Corp. | Versant Venture Capital IV, L. ... | 10% Owner | Buy | J | 2.30 | 817 | 1,878 | 32,394 | 31.6 K to 32.4 K (+2.59 %) |
Jan 16 2019 | OPHT | Ophthotech Corp. | Versant Venture Capital IV, L. ... | 10% Owner | Buy | J | 2.30 | 129,709 | 298,123 | 5,142,333 | 5 M to 5.1 M (+2.59 %) |
Jan 07 2019 | OPHT | Ophthotech Corp. | Westby Keith | SVP & COO | Option Exercise | M | 0.00 | 700 | 0 | 700 | |
Jan 07 2019 | OPHT | Ophthotech Corp. | Westby Keith | SVP & COO | Sell | S | 1.30 | 299 | 389 | 32,606 | 32.9 K to 32.6 K (-0.91 %) |
Jan 07 2019 | OPHT | Ophthotech Corp. | Westby Keith | SVP & COO | Buy | M | 0.00 | 700 | 0 | 32,905 | 32.2 K to 32.9 K (+2.17 %) |
Jan 07 2019 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Option Exercise | M | 0.00 | 6,250 | 0 | 6,250 | |
Jan 07 2019 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Sell | S | 1.30 | 3,859 | 5,017 | 43,164 | 47 K to 43.2 K (-8.21 %) |
Jan 07 2019 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Buy | M | 0.00 | 6,250 | 0 | 47,023 | 40.8 K to 47 K (+15.33 %) |
Jan 04 2019 | OPHT | Ophthotech Corp. | Westby Keith | SVP & COO | Option Exercise | M | 0.00 | 781 | 0 | 0 | |
Jan 04 2019 | OPHT | Ophthotech Corp. | Westby Keith | SVP & COO | Sell | S | 1.24 | 342 | 424 | 32,205 | 32.5 K to 32.2 K (-1.05 %) |
Jan 04 2019 | OPHT | Ophthotech Corp. | Westby Keith | SVP & COO | Buy | M | 0.00 | 781 | 0 | 32,547 | 31.8 K to 32.5 K (+2.46 %) |
Jan 04 2019 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Option Exercise | M | 0.00 | 5,750 | 0 | 0 | |
Jan 04 2019 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Sell | S | 1.24 | 3,637 | 4,510 | 40,773 | 44.4 K to 40.8 K (-8.19 %) |
Jan 04 2019 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Buy | M | 0.00 | 5,750 | 0 | 44,410 | 38.7 K to 44.4 K (+14.87 %) |
Jan 03 2019 | OPHT | Ophthotech Corp. | Roberts Calvin W. | Director | Option Exercise | A | 1.20 | 32,000 | 38,400 | 32,000 | |
Dec 14 2018 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Option Exercise | A | 0.00 | 68,800 | 0 | 68,800 | |
Dec 14 2018 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Option Exercise | A | 1.45 | 137,500 | 199,375 | 137,500 | |
Dec 14 2018 | OPHT | Ophthotech Corp. | Westby Keith | SVP & COO | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Dec 14 2018 | OPHT | Ophthotech Corp. | Westby Keith | SVP & COO | Option Exercise | A | 1.45 | 100,000 | 145,000 | 100,000 | |
Dec 14 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Option Exercise | A | 0.00 | 91,800 | 0 | 91,800 | |
Dec 14 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Option Exercise | A | 1.45 | 183,500 | 266,075 | 183,500 | |
Dec 14 2018 | OPHT | Ophthotech Corp. | Carroll David Francis | SVP, CFO and Treasu ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Dec 14 2018 | OPHT | Ophthotech Corp. | Carroll David Francis | SVP, CFO and Treasu ... | Option Exercise | A | 1.45 | 100,000 | 145,000 | 100,000 | |
Dec 14 2018 | OPHT | Ophthotech Corp. | Graves Adrienne L | Director | Option Exercise | A | 1.45 | 32,000 | 46,400 | 32,000 | |
Jul 11 2018 | OPHT | Ophthotech Corp. | Ross Michael Jay | Director | Option Exercise | A | 2.78 | 16,000 | 44,400 | 16,000 | |
Jul 11 2018 | OPHT | Ophthotech Corp. | Bolte Axel | Director | Option Exercise | A | 2.78 | 16,000 | 44,400 | 16,000 | |
Jul 11 2018 | OPHT | Ophthotech Corp. | Henderson Jane | Director | Option Exercise | A | 2.78 | 16,000 | 44,400 | 16,000 | |
Jul 11 2018 | OPHT | Ophthotech Corp. | Redlick David E | Director | Option Exercise | A | 2.78 | 16,000 | 44,400 | 16,000 | |
Jul 03 2018 | OPHT | Ophthotech Corp. | Carroll David Francis | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 7,500 | 0 | 15,000 | |
Jul 03 2018 | OPHT | Ophthotech Corp. | Carroll David Francis | SVP, CFO and Treasu ... | Sell | S | 2.68 | 2,736 | 7,332 | 8,980 | 11.7 K to 9 K (-23.35 %) |
Jul 03 2018 | OPHT | Ophthotech Corp. | Carroll David Francis | SVP, CFO and Treasu ... | Buy | M | 0.00 | 7,500 | 0 | 11,716 | 4.2 K to 11.7 K (+177.89 %) |
Apr 03 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Option Exercise | M | 0.00 | 18,750 | 0 | 37,500 | |
Apr 03 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Sell | S | 2.69 | 6,838 | 18,394 | 48,407 | 55.2 K to 48.4 K (-12.38 %) |
Apr 03 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Buy | M | 0.00 | 18,750 | 0 | 55,245 | 36.5 K to 55.2 K (+51.38 %) |
Jan 17 2018 | OPHT | Ophthotech Corp. | Henderson Jane | Director | Option Exercise | A | 2.85 | 32,000 | 91,200 | 32,000 | |
Jan 05 2018 | OPHT | Ophthotech Corp. | WOOD BARBARA A | SVP, Gen. Counsel, ... | Option Exercise | M | 0.00 | 1,200 | 0 | 2,400 | |
Jan 05 2018 | OPHT | Ophthotech Corp. | WOOD BARBARA A | SVP, Gen. Counsel, ... | Sell | S | 3.17 | 602 | 1,908 | 16,462 | 17.1 K to 16.5 K (-3.53 %) |
Jan 05 2018 | OPHT | Ophthotech Corp. | WOOD BARBARA A | SVP, Gen. Counsel, ... | Buy | M | 0.00 | 1,200 | 0 | 17,064 | 15.9 K to 17.1 K (+7.56 %) |
Jan 05 2018 | OPHT | Ophthotech Corp. | Westby Keith | SVP & COO | Option Exercise | M | 0.00 | 700 | 0 | 1,400 | |
Jan 05 2018 | OPHT | Ophthotech Corp. | Westby Keith | SVP & COO | Sell | S | 3.17 | 317 | 1,005 | 24,983 | 25.3 K to 25 K (-1.25 %) |
Jan 05 2018 | OPHT | Ophthotech Corp. | Westby Keith | SVP & COO | Buy | M | 0.00 | 700 | 0 | 25,300 | 24.6 K to 25.3 K (+2.85 %) |
Jan 05 2018 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Option Exercise | M | 0.00 | 6,250 | 0 | 12,500 | |
Jan 05 2018 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Sell | S | 3.17 | 3,798 | 12,040 | 38,660 | 42.5 K to 38.7 K (-8.95 %) |
Jan 05 2018 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Buy | M | 0.00 | 6,250 | 0 | 42,458 | 36.2 K to 42.5 K (+17.26 %) |
Jan 04 2018 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Option Exercise | M | 0.00 | 5,750 | 0 | 5,750 | |
Jan 04 2018 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Sell | S | 3.24 | 3,516 | 11,392 | 36,208 | 39.7 K to 36.2 K (-8.85 %) |
Jan 04 2018 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Buy | M | 0.00 | 5,750 | 0 | 39,724 | 34 K to 39.7 K (+16.92 %) |
Jan 04 2018 | OPHT | Ophthotech Corp. | WOOD BARBARA A | SVP, General Counse ... | Option Exercise | M | 0.00 | 1,375 | 0 | 1,375 | |
Jan 04 2018 | OPHT | Ophthotech Corp. | WOOD BARBARA A | SVP, General Counse ... | Sell | S | 3.24 | 694 | 2,249 | 15,864 | 16.6 K to 15.9 K (-4.19 %) |
Jan 04 2018 | OPHT | Ophthotech Corp. | WOOD BARBARA A | SVP, General Counse ... | Buy | M | 0.00 | 1,375 | 0 | 16,558 | 15.2 K to 16.6 K (+9.06 %) |
Jan 04 2018 | OPHT | Ophthotech Corp. | Westby Keith | SVP & COO | Option Exercise | M | 0.00 | 781 | 0 | 781 | |
Jan 04 2018 | OPHT | Ophthotech Corp. | Westby Keith | SVP & COO | Sell | S | 3.24 | 356 | 1,153 | 24,600 | 25 K to 24.6 K (-1.43 %) |
Jan 04 2018 | OPHT | Ophthotech Corp. | Westby Keith | SVP & COO | Buy | M | 0.00 | 781 | 0 | 24,956 | 24.2 K to 25 K (+3.23 %) |
Jan 03 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Option Exercise | M | 0.00 | 20,420 | 0 | 0 | |
Jan 03 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Sell | S | 3.19 | 8,089 | 25,804 | 36,495 | 44.6 K to 36.5 K (-18.14 %) |
Jan 03 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Buy | M | 0.00 | 20,420 | 0 | 44,584 | 24.2 K to 44.6 K (+84.51 %) |
Jan 03 2018 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Option Exercise | M | 0.00 | 30,480 | 0 | 0 | |
Jan 03 2018 | OPHT | Ophthotech Corp. | GUYER DAVID R | Executive Chairman | Sell | S | 3.19 | 16,520 | 52,699 | 33,974 | 50.5 K to 34 K (-32.72 %) |